It turns out the drug ecstasy, which is generally used recreationally, may also have some medicinal value. The New York Post reports that the FDA, which has already held successful preliminary trials, is moving forward with a large-scale study of the possible use of ecstasy as a prescription drug to treat post-traumatic stress disorder.
The study, which was approved Tuesday, could lead to the legalization of the drug. “If the results are favorable, the drug also known as MDMA would be available to patients as early as 2021,” The Post reports.
“The trial, sponsored by the Multidisciplinary Association for Psychedelic Studies, reportedly will include 230 participants. Past research funded by the organization has studied the drug’s effect on veterans, sexual assault victims, police and firefighters suffering from PTSD,” the report notes.